Cite
MLA Citation
Jeffrey A Cohen et al.. “Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study.” Multiple sclerosis, vol. 25, 2019, pp. 1255–1262. http://access.bl.uk/ark:/81055/vdc_100086475289.0x000009